TFFP (TFF Pharmaceuticals, Inc.) Future Price to Earnings
TFF Pharmaceuticals relies on a unique drug-freezing powder platform through B2B contracts. The issuer's expected P/E on the GURU.Markets chart reflects market sentiment, with the indicator reaching 0.00. While the company is valued for converting injections into inhalations, delisting risks and a liquidity shortage are exerting significant pressure on the stock price.
Summary analytical data breakdowns for TFF Pharmaceuticals, Inc (TFFP)
- current price and projected stock value:
- business market valuation indicators:
- balance sheet equity data:
- debt level and financial liquidity data:
Total Debt to Capital TFF Pharmaceuticals|TFFP - Long-Term Liabilities to Capital|Short-Term Debt to Equity TFF Pharmaceuticals|TFFP - Aggregate Debt Obligations|Debt to Book Value TFF Pharmaceuticals Inc.|TFFP - Amount of Long-Term Liabilities|Company Short-Term Debts TFF Pharmaceuticals|Quick Ratio tffpharma.com
- financial results and valuation multiples details:
TFFP - Profit After Tax|Future Profit TFF Pharmaceuticals|TFFP - Company Value to Net Income|Future Price to Earnings TFF Pharma|TFFP - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple TFF Pharmaceuticals Inc.|TFFP - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) TFF Pharmaceuticals|TFFP - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months tffpharma.com|TFFP - Earnings per share increase in current year|Net earnings per share growth forecast for next year TFF Pharmaceuticals
Fundamental valuation:TFF Pharmaceuticals, Inc. TFFP
The forward P/E determines the fair value of assets by correlating the current market share price with the projected net income for the upcoming period. By analyzing the current forward P/E of TFF Pharmaceuticals (TFFP), an investor assesses market expectations for the monetization of thin-film freezing technology, where the potential for long-term royalties from platform licensing drives the coefficient's dynamics and the search for a balance between risks and future earnings.
Key competitors
Projected Price to Earnings HLN (Haleon)|KVUE (Kenvue Inc) - Future Price to Earnings Multiple|Future Price to Earnings Verona Pharma Corp VRNA|Jyong Bio (MENS) - Projected Price to Earnings Ratio|LGND: Projected Price to Earnings|amneal.com - Market Cap to Future Earnings Ratio|PRGO: Forward P/E Multiple|Alvotech S.A. - Future Price to Earnings Multiple|LQDA (Liquidia Technologies) - Forward P/E Multiple|Projected Price to Earnings Ratio Galapagos Corp GLPG|Future Price to Earnings ANI Pharmaceuticals (ANIP)|MNKD (mannkindcorp.com) - Future Price to Earnings Multiple|Amphastar Pharmaceuticals, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio PCRX (Pacira Pharmaceuticals)|ARS Pharma - Forward P/E Multiple|Price to Expected Earnings Ratio TBPH|AQST: Forward P/E Multiple|Price to Expected Earnings Ratio SCPH (scPharmaceuticals)|Projected Price to Earnings TECX|TNXP: Future Price to Earnings Multiple|Future Price to Earnings China SXT Pharmaceuticals (SXTC)|EPRX: Price to Expected Earnings Ratio|Forward P/E Multiple BHST (BioHarvest Sciences)|Future Price to Earnings Multiple EXOZ|Oramed Pharma - Forward P/E Multiple|ENTX - Forward P/E Multiple|MindWalk (HYFT) - Future Price to Earnings|ABVC BioPharma, Inc - Future Price to Earnings Multiple|Future Price to Earnings Cumberland Pharmaceuticals|Projected Price to Earnings quantumbiopharma.com (QNTM)|Forward P/E Multiple FGEN|Forward P/E Multiple Telomir Pharmaceuticals Inc (TELO)|Forward P/E Multiple RANI (Rani Therapeutics Holdings, Inc.)|SNYR - Projected Price to Earnings|Rallybio Corp. - Forward P/E Multiple|Projected Price to Earnings Ratio Lexaria Bioscience|PULM (Pulmatrix) - Projected Price to Earnings|Pheton Holdings (PTHL) - Forward P/E Multiple|Projected Price to Earnings APM|LYRA (Lyra Therapeutics Inc) - Market Cap to Future Earnings Ratio|Forward P/E Multiple IBO|Market Cap to Projected Earnings tnfpharma.com|Forward P/E Multiple YCBD (cbdMD)|PRFX - Projected Price to Earnings|Auris Medical - Forward P/E Multiple|LIPO - Forward P/E Multiple|OptiNose, Inc. (OPTN) - Future Price to Earnings|PIRS (pieris.com) - Future Price to Earnings|Future Price to Earnings Procaps|Petros Pharmaceuticals Inc (PTPI) - Market Cap to Projected Earnings|Projected Price to Earnings QLI (Qilian International Holding Group Limited)|Market Cap to Future Earnings Ratio SLRN
